Thema
Antibodies, Monoclonal, Humanized
354
Journal Article
213
Antibodies, Monoclonal
181
Letter
130
dupilumab
81
420K487FSG
77
Adalimumab
72
FYS6T7F842
72
Research Support, Non-U.S. Gov't
64
Multicenter Study
60
Randomized Controlled Trial
59
Dermatologic Agents
55
psoriasis
53
Case Reports
49
Etanercept
47
OP401G7OJC
47
secukinumab
42
DLG4EML025
41
Clinical Trial, Phase III
38
atopic dermatitis
38
Comparative Study
37
XX2MN88N5D
37
efalizumab
37
Tumor Necrosis Factor-alpha
36
Immunoglobulin G
35
ixekizumab
34
B72HH48FLU
33
Comment
33
Infliximab
33
Review
33
BTY153760O
32
Receptors, Tumor Necrosis Factor
32
FU77B4U5Z0
31
Ustekinumab
31
Immunosuppressive Agents
26
safety
23
efficacy
21
biologics
20
brodalumab
20
6ZA31Y954Z
19
Clinical Trial, Phase II
19
Biological Products
18
Systematic Review
18
Anti-Inflammatory Agents
17
Interleukin-17
16
089658A12D
14
guselkumab
14
Antineoplastic Agents
13
Methotrexate
12
Research Support, N.I.H., Extramural
12
mehr ...